Boosting glycogen breakdown in neurons with tau-related damage improves symptoms of neurodegeneration, a potential strategy for Alzheimer's and related diseases.
“Neurodegenerative diseases like Alzheimer's disease and frontotemporal lobar degeneration are characterized by the abnormal buildup of tau, a protein that damages brain cells and drives cognitive decline.”